查看購物車
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1999423

玻璃體切除術醫療設備市場：2026-2032年全球市場預測（依產品類型、技術類型、規格尺寸、手術類型、使用模式、手術環境、臨床應用、最終用戶和銷售管道）

Vitrectomy Devices Market by Product Type, Technology Type, Gauge Size, Procedure Type, Usage Pattern, Surgery Setting, Clinical Application, End User, Sales Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 197 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2025 年，玻璃體切除術醫療設備市場價值將達到 25.5 億美元，到 2026 年將成長至 29.3 億美元，到 2032 年將達到 68.5 億美元，複合年成長率為 15.14%。

主要市場統計數據
基準年 2025 25.5億美元
預計年份：2026年 29.3億美元
預測年份 2032 68.5億美元
複合年成長率 (%) 15.14%

鑑於玻璃體視網膜手術領域不斷變化的格局，我們的目標是使設備創新與臨床需求和醫療保健服務的現實相一致。

在臨床實務、技術和醫療服務三大趨勢交織的背景下，玻璃體切除手術器材市場正處於一個轉捩點。器械形狀和視覺化技術的創新，以及手術技術向微創方向的改進，正在改變玻璃體視網膜外科醫師診斷和治療複雜後段眼疾的方式。同時，醫療服務模式和供應鏈生態系統也在不斷演變，迫使器材製造商和醫療系統重新評估產品系列、籌資策略和臨床訓練路徑。

近期技術和營運方面的變革如何重塑玻璃體視網膜醫學的手術流程、採購預期和供應鏈優先事項。

近年來，玻璃體切除術設備的技術能力及其應用環境都發生了變革性的變化。技術進步的核心是3D和光學同調斷層掃描（OCT）整合視覺化系統，這些系統能夠提供更豐富的術中資料和更佳的深度感知，從而實現更精準的膜分離和視網膜操作。可視化技術的進步與探針工程的進步相輔相成。更細的探針、更精密的吸力和切割機制以及高性能材料改善了對周邊視網膜的暴露，並減少了手術組織損傷。伴隨這些技術創新，外科醫師也發生了觀念上的轉變，他們要求手術創傷更小、手術時間更短。

本研究評估了近期美國關稅趨勢如何促使整個玻璃體切除手術生態系統進行供應鏈轉型、籌資策略調整和採購重新評估。

美國近期關稅措施和貿易政策調整的累積影響，為製造商、經銷商和醫療保健服務體系的策略規劃帶來了新的複雜性。關稅帶來的成本壓力體現在進口零件和成品系統的接收成本增加，迫使製造商重新評估籌資策略，重新談判供應商契約，並在某些情況下加快生產能力的轉移或多元化。這些因應措施並非立竿見影，而是引發一系列營運調整，影響前置作業時間、營運資金需求和庫存政策。

細分市場的洞察揭示了設備分類、規格、最終用戶環境、臨床應用和材料選擇如何影響產品的採用和採購。

詳細的市場細分有助於觀點臨床需求、技術差異和採購選擇之間的交集。以設備類別（例如光源、視覺化系統、玻璃體切除探針和玻璃體切除系統）分析市場，可以突出不同類別之間的差異，並展現出各自獨特的創新和商業化路徑。例如，視覺化系統（包括 3D 視覺化和 OCT 成像）正在與數位化工作流程整合，以擴展術中診斷和術者引導。光源正在發展成為支援高清可視化的長壽命、高能效技術，而玻璃體切除系統則正在整合先進的流體動力學和吸力控制技術，以提高安全性和手術控制。對 20G、23G、25G 和 27G 尺寸的玻璃體切除探針進行研究，結果表明，器械剛度、端口尺寸和創傷治療動力學之間存在權衡，這會影響術者的偏好和手術選擇。

世界主要地區在法規結構、採購行為和臨床能力方面的區域差異如何影響醫療設備的採用？

區域趨勢對玻璃體視網膜醫療設備市場的監管環境、部署計畫和分銷策略有顯著影響。在美洲，臨床實踐模式和資金籌措便利性推動了先進設備和整合式視覺化解決方案的快速普及，尤其是在三級醫療機構和高流量門診手術中心。此外，大規模醫療系統內的報銷機制和大量採購也會影響產品選擇，使那些具有高效運作和完善培訓支援的設備更受青睞。

競爭策略和合作夥伴關係推動了成熟製造商和敏捷創新者之間的產品採用和臨床整合。

玻璃體切除器材領域的主要企業正透過產品創新、策略夥伴關係和服務導向商業模式相結合的方式，保持競爭優勢。許多成熟的器材製造商優先將先進的視覺化技術整合到其平台中，利用軟體功能和模組化硬體來適應不同的臨床工作流程。此類整合通常與全面的培訓計劃和遠端支援能力相結合，以降低臨床應用門檻。

為製造商和供應商提供可操作的策略行動，以增強玻璃體視網膜設備的臨床引入、供應彈性和以價值為導向的商業化。

行業領導者應優先採取一系列切實可行的步驟，將技術潛力轉化為永續的臨床和商業性成功。首先，研發重點應與可驗證的臨床結果和使用者體驗的提升保持一致。投資於能夠顯著縮短手術時間、降低併發症率或減少後續資源利用的功能，能夠增強在採購資源緊張的環境下部署這些功能的合理性。其次，應發展靈活的商業模式，以適應預算有限的門診中心和綜合醫院系統。例如，可以採用綜合服務合約、基於結果的合約以及可根據臨床需求進行擴展的模組化產品方案。

採用嚴謹的混合方法研究途徑，結合對臨床醫師的訪談、技術審查和檢驗，確保獲得可靠、可操作的見解。

本分析所依據的研究採用了混合方法，強調對來自臨床醫生的原始資料、行業相關人員的訪談以及輔助二級資訊來源進行交叉檢驗。原始研究包括與玻璃體視網膜外科醫生、手術室護理師、採購經理和臨床工程師進行結構化訪談，以了解實際的醫療設備使用模式、工作流程挑戰和未滿足的臨床需求。這些訪談旨在收集技術方面的見解，例如測量尺寸、視覺化技術和儀器的人體工學設計，以及與採購和維護相關的營運重點。

整合關鍵見解，將技術進步、營運韌性和臨床價值連結起來，為相關人員提供一致的策略方向。

總之，玻璃體切除術器械生態系統正受到三大同步發展的重塑：視覺化技術的進步、器械的小型化以及醫療服務模式的演變。所有這一切都發生在一個供應鏈脆弱性和支付方監管日益重要的商業環境中。能夠將技術創新與切實可行的商業策略相結合、展現明確的臨床效益、確保供應韌性並提供靈活的採購管道以滿足醫療服務提供者多樣化需求的機構，將是最終取得成功的。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席體驗長觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 波特五力分析
  • PESTEL 分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：美國關稅的累積影響，2025年

第7章：人工智慧的累積影響，2025年

第8章：玻璃體切除術醫療設備市場：依產品類型分類

  • 玻璃體切除系統
    • 一體化白內障和玻璃體切除系統
    • 獨立式玻璃體切除術主機
  • 玻璃體切除探針
    • 氣動探針
    • 電動探頭和超音波探頭
  • 照明設備
    • 光源
    • 光纖照明電纜
  • 手術包
    • 包裝好的一次性試劑盒
    • 客製化手術套餐
  • 配件
    • 套管和穿刺器
    • 輸液管路和導管
    • 腳踏開關和控制踏板
    • 可視化和觀察配件
      • 隱形眼鏡
      • 非接觸式觀測系統

第9章：玻璃體切除術醫療設備市場：依技術類型分類

  • 切割機構技術
    • 氣動切割技術
    • 電切割技術
    • 超音波和超音波技術
  • 照明技術
    • 氙氣燈
    • LED照明
  • 流體管理技術
    • 蠕動幫浦系統
    • 文丘里泵浦系統
    • 混合泵浦系統
  • 視覺化技術
    • 接觸觀察技術
    • 非接觸式觀察技術
    • 數位視覺化系統

第10章：玻璃體切除術醫療設備市場（依規格尺寸分類）

  • 20號口徑
  • 23號口徑
  • 25號口徑
  • 27號口徑

第11章：依手術類型分類的玻璃體切除術醫療設備市場

  • 後段手術
    • 脈衝平面玻璃體切除手術
    • 視網膜剝離修復手術
    • 黃斑手術
  • 前段手術
    • 白內障手術期間進行前部玻璃體切除手術
    • 晶狀體併發症的前部玻璃體切除手術
  • 聯合手術
    • 超音波乳化聯合玻璃體切除手術
    • 玻璃體切除手術合併二次人工水晶體植入術

第12章：玻璃體視網膜切除術醫療設備市場（依應用領域分類）

  • 免洗設備
    • 探針和切割器
    • 套管和穿刺器
    • 手術包
  • 可重複使用設備
    • 主機和控制單元
    • 光源
    • 腳踏開關
    • 可重複使用設備

第13章：玻璃體切除術醫療設備市場（依手術環境分類）

  • 住院設施
  • 門診及日間護理設施
  • 診所

第14章：玻璃體切除術醫療設備市場（依臨床應用分類）

  • 糖尿病視網膜病變
    • 增殖性糖尿病視網膜病變
    • 糖尿病黃斑部水腫
  • 視網膜剝離
    • 裂孔性視網膜剝離
    • 牽拉性視網膜剝離
    • 視網膜剝離是由複雜機制引起的
  • 黃斑部疾病
    • 黃斑裂孔
    • 視網膜前膜
  • 玻璃體出血
  • 葡萄膜炎和眼內炎
  • 眼外傷

第15章：玻璃體切除術醫療設備市場：依最終用戶分類

  • 醫院
    • 三級醫療機構
    • 當地醫院
  • 眼科診所
    • 單一專科診所
    • 全科診所
  • 門診手術中心
  • 學術研究機構

第16章：玻璃體切除術醫療設備市場：依銷售管道分類

  • 直銷
    • 競標醫療機構
    • 直接向醫生銷售
  • 透過分銷商銷售
  • 線上電子採購平台

第17章 玻璃體切除術醫療設備市場：依地區分類

  • 北美洲和南美洲
    • 北美洲
    • 拉丁美洲
  • 歐洲、中東和非洲
    • 歐洲
    • 中東
    • 非洲
  • 亞太地區

第18章：玻璃體切除術醫療設備市場：依類別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第19章 玻璃體切除術醫療設備市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第20章：美國玻璃體視網膜醫療設備市場

第21章：中國玻璃體視網膜醫療設備市場

第22章 競爭情勢

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年
  • Alcon Inc.
  • Bausch+Lomb Corporation
  • Blink Medical Ltd.
  • BVI Medical, Inc.
  • Carl Zeiss Meditec AG
  • DORC Holding BV
  • Geuder AG
  • Haag-Streit Holding AG
  • HOYA Medical Singapore Pte. Ltd.
  • Iridex Corporation
  • Johnson & Johnson Vision Care, Inc.
  • MedOne Surgical, Inc.
  • Medtronic plc
  • NIDEK Co., Ltd.
  • OCULUS Optikgerate GmbH
  • Oertli Instrumente AG
  • Peregrine Surgical LLC
  • Synergetics USA, Inc.
  • Topcon Corporation
Product Code: MRR-563BF1FCEC7D

The Vitrectomy Devices Market was valued at USD 2.55 billion in 2025 and is projected to grow to USD 2.93 billion in 2026, with a CAGR of 15.14%, reaching USD 6.85 billion by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 2.55 billion
Estimated Year [2026] USD 2.93 billion
Forecast Year [2032] USD 6.85 billion
CAGR (%) 15.14%

Framing the evolving landscape of vitreoretinal surgery to align device innovation with clinical needs and healthcare delivery realities

The vitrectomy devices landscape is at an inflection point shaped by converging clinical, technological, and care-delivery dynamics. Innovations in instrument geometry and visualization, combined with procedural refinements toward minimally invasive approaches, are transforming how vitreoretinal surgeons diagnose and treat complex posterior segment disease. At the same time, provider models and supply chain ecosystems are evolving, requiring device manufacturers and health systems to reassess product portfolios, procurement strategies, and clinical training pathways.

This introduction frames the subsequent analysis by situating device innovation within practical clinical constraints and commercial realities. Emerging visualization modalities and refined probe designs are enhancing surgical precision and ergonomics, while material and disposability considerations are reshaping perioperative economics and infection control protocols. Concurrently, shifts in where care is delivered-from inpatient hospital theaters toward ambulatory surgery centers and specialty clinics-are influencing equipment purchasing patterns, service requirements, and capital allocation decisions.

By synthesizing recent clinical literature, surgeon practice patterns, and industry developments, the following sections outline the transformative shifts, tariff-driven headwinds, segmentation-driven opportunities, regional dynamics, competitive maneuvers, and pragmatic recommendations that executives and surgeons need to consider in the coming strategic horizon.

How recent technological and operational shifts are reshaping surgical practice patterns, procurement expectations, and supply chain priorities in vitreoretinal care

The past several years have produced transformative shifts that are redefining both the technical capabilities of vitrectomy devices and the larger environment in which they are deployed. Technological evolution has centered on three-dimensional and optical coherence tomography-integrated visualization systems that provide richer intraoperative data and improve depth perception, enabling more precise membrane peeling and retinal maneuvers. Visualization advances are complemented by progress in probe engineering: slimmer gauges, refined aspiration and cut mechanisms, and smarter materials have improved access to the peripheral retina and reduced surgical trauma. These technical innovations are accompanied by a cultural shift among surgeons toward less invasive techniques and shorter procedure times.

Concurrently, the operational context for device adoption has changed. Ambulatory surgery centers are increasing their share of elective vitreoretinal procedures, which in turn emphasizes compact, portable systems and streamlined consumable workflows. Procurement teams are seeking solutions that balance up-front capital with predictable per-procedure costs, and value propositions that include clinical training, remote diagnostics, and service-level guarantees are gaining prominence. Supply chain resilience has become a strategic priority after disruptions highlighted the risks of overreliance on single-source suppliers and distant manufacturing footprints. As a result, manufacturers are accelerating diversification of component sourcing and exploring nearshoring options to reduce lead times and regulatory friction.

Finally, regulatory and reimbursement landscapes are nudging innovation toward demonstrable clinical benefit and procedural efficiency. Coverage policies increasingly demand evidence of improved outcomes or cost offsets tied to device use, while hospital administrators and payers scrutinize incremental costs associated with advanced visualization or single-use instruments. The net effect of these forces is a landscape in which technical capability must be paired with clear clinical and economic narratives to achieve adoption at scale.

Assessing how recent United States tariff dynamics are prompting supply chain pivots, sourcing strategies, and procurement reappraisals across the vitrectomy ecosystem

The cumulative impact of recent tariff actions and trade policy adjustments in the United States has injected a new layer of complexity into strategic planning for manufacturers, distributors, and provider systems. Tariff-driven cost pressure has manifested through increased landed costs for imported components and finished systems, prompting manufacturers to revisit sourcing strategies, negotiate new supplier agreements, and in some cases accelerate the relocation or diversification of manufacturing capacity. These responses are not instantaneous; rather, they produce a cascade of operational adjustments that affect lead times, working capital requirements, and inventory policies.

On the supply side, manufacturers with globally dispersed production have begun to prioritize component rationalization and supplier consolidation to reduce exposure to tariff volatility. In parallel, some firms are evaluating alternatives such as strategic nearshoring, dual-sourcing critical components, and redesigning assemblies to substitute tariff-exposed parts with domestically sourced equivalents. These measures help mitigate recurring tariff costs but often require upfront capital and qualification timelines, creating transitional cost burdens that can influence product launch cadence and pricing strategies.

For healthcare providers and purchasers, the tariff environment can lead to tighter negotiations on service contracts and heightened scrutiny of per-procedure consumable costs. Institutions that rely on imported vitrectomy probes, visualization platforms, or ancillary disposables may experience procurement delays or price adjustments, prompting a reexamination of preferred vendor lists and longer-term contracting arrangements. Some providers are responding by increasing inventory buffers or by partnering with vendors who can demonstrate resilient supply chains and local service capabilities.

Clinically, the potential pass-through of increased device costs may influence adoption choices for newer technologies that carry incremental procurement premiums, such as integrated OCT visualization or advanced single-use instrumentation. Manufacturers and clinical advocates must therefore develop compelling health economic narratives that articulate either improved clinical outcomes or total-cost-of-care benefits. In sum, tariff-related pressures are accelerating strategic realignment across R&D prioritization, sourcing, and commercialization pathways, making supply chain agility and cost transparency essential competencies for market participants.

Segment-driven insights revealing how device class, gauge, end-user setting, clinical application, and material choices shape product adoption and procurement

Detailed segmentation provides a lens for understanding where clinical demand, technological differentiation, and procurement choices intersect. When the market is examined by device category-covering Light Sources, Visualization Systems, Vitrectomy Probes, and Vitrectomy Systems-the distinctions illuminate different innovation and commercialization trajectories. Visualization Systems, for instance, which include 3D Visualization and OCT Imaging, are converging with digital workflows to expand intraoperative diagnostics and surgeon guidance. Light sources are evolving toward longer-life, energy-efficient technologies that support high-fidelity visualization, while vitrectomy systems integrate advanced fluidics and aspiration control to improve safety and procedural control. Vitrectomy Probes, studied across 20G, 23G, 25G, and 27G, demonstrate the trade-offs between instrument rigidity, port size, and wound healing dynamics that inform surgeon preference and procedural selection.

Examining gauge size specifically highlights a clinical preference trend toward smaller-diameter instruments that reduce operative trauma and accelerate recovery, though larger gauges retain importance for complex cases that require greater flow and instrument robustness. End user segmentation-across Ambulatory Surgery Centers, Hospitals, and Ophthalmology Clinics-reveals divergent procurement behaviors and equipment requirements. Ambulatory surgery centers often prioritize compact, modular systems and predictable consumable pricing, whereas hospitals may emphasize integration with enterprise service contracts and advanced imaging suites. Ophthalmology clinics focused on diagnostics and minor procedures may select systems optimized for throughput and footprint efficiency.

Application-driven segmentation across Diabetic Retinopathy, Macular Hole, Retinal Detachment, and Vitreous Hemorrhage indicates that device selection is closely tied to pathology-specific needs: cases involving peripheral retinal pathology or extensive membrane work may favor particular probe gauges and fluidics capabilities, while macular procedures often benefit from enhanced visualization and microinstruments. Material considerations, divided into Disposable and Reusable options, shape procurement models and perioperative workflows; disposables offer infection-control advantages and predictable per-case costs, whereas reusable instruments require sterilization infrastructure and create different total-cost dynamics. Together, these segmentation perspectives clarify where clinical utility, operational constraints, and commercial models align and conflict, guiding product development and go-to-market decisions.

How geographic regulatory frameworks, purchasing behaviors, and clinical capacity differences are steering device adoption across major global regions

Regional dynamics exert a strong influence on regulatory pathways, adoption timelines, and distribution strategies across the vitreoretinal device landscape. In the Americas, clinical practice patterns and capital availability support rapid uptake of advanced instrumentation and integrated visualization solutions, particularly in tertiary centers and high-volume ambulatory surgery settings. Reimbursement frameworks and consolidated purchasing at large health systems also shape product selection, favoring devices that demonstrate operational efficiencies and training support.

The Europe, Middle East & Africa region presents a heterogeneous environment where regulatory harmonization in parts of Europe facilitates cross-border product registrations, while other markets exhibit fragmented pathways that require localized clinical evidence and distributor networks. Procurement mechanisms in this region often balance centralized hospital purchasing with national-level reimbursement considerations, which can influence how quickly new technologies gain traction. Emerging markets within the region can be receptive to cost-effective innovations and local manufacturing partnerships that reduce landed costs and improve service access.

Across the Asia-Pacific region, rapid expansion of surgical capacity, investments in specialty clinics, and growing surgeon expertise drive demand for both foundational vitrectomy systems and cutting-edge visualization technologies. Local manufacturing ecosystems and strategic partnerships with global suppliers are enabling faster scale-up and customization for regional clinical preferences. However, differences in regulatory requirements and purchasing behavior across countries necessitate tailored market-entry strategies that address clinical training, after-sales service, and supply chain resilience.

Competitive strategies and collaborative partnerships that are enabling established manufacturers and agile innovators to advance adoption and clinical integration

Leading companies in the vitrectomy devices space are deploying a mix of product innovation, strategic partnerships, and service-oriented commercial models to maintain competitive advantage. Many established device manufacturers are prioritizing integration of advanced visualization modalities into their platforms, leveraging software-enabled features and modular hardware to meet diverse clinical workflows. Such integration often pairs with enhanced training programs and remote support capabilities to reduce the friction associated with clinical adoption.

Strategic collaborations between instrument makers and imaging or software specialists are becoming more commonplace, as firms seek to offer end-to-end solutions that combine high-fidelity visualization with intelligent intraoperative guidance. Companies that invest in robust post-market surveillance and evidence generation programs are better positioned to support reimbursement discussions and clinician acceptance, especially for technologies that claim improvements in precision or efficiency. Manufacturing footprint optimization and supply chain transparency are also central to competitiveness; firms that demonstrate reliable, responsive distribution and local service capabilities are more attractive partners to hospitals and ambulatory centers focused on uptime and predictable operating costs.

Smaller and more nimble innovators are carving niches by focusing on single-use probes, ergonomic instrument design, or cloud-enabled analytics that augment surgical decision-making. These entrants often seek partnerships with established distributors to scale access while preserving the agility to iterate product features rapidly. Across the competitive set, success increasingly depends not only on technical superiority but on the ability to present a coherent clinical value proposition, to support customers through training and maintenance, and to align pricing with the economic realities of different care settings.

Practical strategic actions for manufacturers and providers to enhance clinical adoption, supply resilience, and value-oriented commercialization in vitreoretinal devices

Industry leaders should prioritize a set of actionable initiatives to translate technological promise into sustainable clinical and commercial success. First, align R&D priorities with demonstrable clinical outcomes and user experience improvements; investing in features that materially reduce procedure time, complication rates, or downstream resource utilization will strengthen the case for adoption in constrained procurement environments. Second, develop flexible commercial models that accommodate both capital-constrained ambulatory centers and integrated hospital systems, such as bundled service agreements, performance-based contracts, and modular product offerings that scale with clinical need.

Third, strengthen supply chain resilience through supplier diversification, component standardization, and strategic nearshoring where feasible; these steps reduce exposure to tariff volatility and improve lead time predictability. Fourth, invest in clinician training and digital-enabled support, including simulation, telementoring, and outcome-tracking tools, to shorten the learning curve for advanced visualization and new probe technologies. Fifth, pursue targeted evidence-generation programs that capture real-world clinical and health economic outcomes across the full spectrum of applications, with emphasis on those diagnoses where improved visualization and instrument design can meaningfully change patient trajectories.

Finally, adopt a regionalized go-to-market approach that tailors regulatory, pricing, and service strategies to the distinctive characteristics of each geography. This includes building local partnerships, establishing robust after-sales networks, and offering flexible procurement options to meet the differing needs of ambulatory centers, hospitals, and specialty clinics. Collectively, these recommendations create a blueprint for converting innovation into durable clinical adoption and commercial performance.

A rigorous mixed-methods research approach combining clinician interviews, technical review, and validation to ensure robust and actionable insights

The research behind this analysis employed a mixed-methods approach that emphasizes triangulation between primary clinician input, industry stakeholder interviews, and corroborative secondary sources. Primary research included structured conversations with vitreoretinal surgeons, operating room nurses, procurement leaders, and clinical engineers to surface real-world device usage patterns, pain points in workflow, and unmet clinical needs. These engagements were designed to capture both technical insights-such as preferences for gauge size, visualization modalities, and instrument ergonomics-and operational priorities related to procurement and serviceability.

Secondary research synthesized peer-reviewed clinical literature, regulatory guidance documents, product technical specifications, and vendor collateral to inform device feature analysis and to contextualize clinical claims. To enhance analytical rigor, inputs from primary and secondary sources were cross-validated through follow-up interviews and scenario testing with key opinion leaders. Segmentation frameworks were developed iteratively to reflect device category, gauge size, end-user setting, clinical application, and material type, enabling granular alignment between clinical use cases and product attributes.

Limitations and potential biases were addressed through careful respondent selection to ensure representation across practice settings and geographies, and by documenting areas where evidence is emerging rather than conclusive. Where possible, findings emphasize directional trends and qualitative insights rather than specific quantitative estimates, ensuring that recommendations remain robust across plausible market conditions.

Synthesis of essential insights tying technological progress, operational resilience, and clinical value into a cohesive strategic direction for stakeholders

In conclusion, the vitrectomy device ecosystem is being reshaped by concurrent advances in visualization, instrument miniaturization, and evolving care delivery models, all within a commercial environment increasingly defined by supply chain sensitivity and payer scrutiny. The most successful organizations will be those that can integrate technical innovation with pragmatic commercial strategies-demonstrating clear clinical benefits, ensuring supply resilience, and offering flexible purchasing pathways that align with diverse provider needs.

Moving forward, manufacturers should prioritize clinician-focused design, comprehensive training and support, and evidence programs that articulate both clinical and economic value. Providers and procurement leaders should emphasize total-cost perspectives, supply chain transparency, and partnerships that deliver predictable service and clinical outcomes. By adopting a coordinated approach across product development, commercialization, and operational execution, stakeholders can accelerate the translation of technology into improved patient care while mitigating the systemic risks introduced by trade and regulatory headwinds.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Porter's Five Forces Analysis
  • 4.4. PESTLE Analysis
  • 4.5. Market Outlook
    • 4.5.1. Near-Term Market Outlook (0-2 Years)
    • 4.5.2. Medium-Term Market Outlook (3-5 Years)
    • 4.5.3. Long-Term Market Outlook (5-10 Years)
  • 4.6. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Vitrectomy Devices Market, by Product Type

  • 8.1. Vitrectomy Systems
    • 8.1.1. Integrated Phaco-Vitrectomy Systems
    • 8.1.2. Standalone Vitrectomy Consoles
  • 8.2. Vitrectomy Probes
    • 8.2.1. Pneumatic Probes
    • 8.2.2. Electric And Hypersonic Probes
  • 8.3. Illumination Devices
    • 8.3.1. Light Sources
    • 8.3.2. Fiber Optic Illumination Cables
  • 8.4. Surgical Packs
    • 8.4.1. Packaged Disposable Kits
    • 8.4.2. Custom Procedure Packs
  • 8.5. Accessories
    • 8.5.1. Cannulas And Trocars
    • 8.5.2. Infusion Lines And Tubing
    • 8.5.3. Footswitches And Control Pedals
    • 8.5.4. Visualization And Viewing Accessories
      • 8.5.4.1. Contact Lenses
      • 8.5.4.2. Non-Contact Viewing Systems

9. Vitrectomy Devices Market, by Technology Type

  • 9.1. Cutting Mechanism Technology
    • 9.1.1. Pneumatic Cutting Technology
    • 9.1.2. Electric Cutting Technology
    • 9.1.3. Ultrasonic And Hypersonic Technology
  • 9.2. Illumination Technology
    • 9.2.1. Xenon Illumination
    • 9.2.2. LED Illumination
  • 9.3. Fluidics Management Technology
    • 9.3.1. Peristaltic Pump Systems
    • 9.3.2. Venturi Pump Systems
    • 9.3.3. Hybrid Pump Systems
  • 9.4. Visualization Technology
    • 9.4.1. Contact Viewing Technology
    • 9.4.2. Non-Contact Viewing Technology
    • 9.4.3. Digital Visualization Systems

10. Vitrectomy Devices Market, by Gauge Size

  • 10.1. 20 Gauge
  • 10.2. 23 Gauge
  • 10.3. 25 Gauge
  • 10.4. 27 Gauge

11. Vitrectomy Devices Market, by Procedure Type

  • 11.1. Posterior Segment Procedures
    • 11.1.1. Pars Plana Vitrectomy
    • 11.1.2. Retinal Detachment Repair
    • 11.1.3. Macular Surgery Procedures
  • 11.2. Anterior Segment Procedures
    • 11.2.1. Anterior Vitrectomy During Cataract Surgery
    • 11.2.2. Anterior Vitrectomy For Lens Complications
  • 11.3. Combined Procedures
    • 11.3.1. Phaco-Vitrectomy Procedures
    • 11.3.2. Vitrectomy With Secondary Lens Implantation

12. Vitrectomy Devices Market, by Usage Pattern

  • 12.1. Single-Use Devices
    • 12.1.1. Probes And Cutters
    • 12.1.2. Cannulas And Trocars
    • 12.1.3. Surgical Packs
  • 12.2. Reusable Devices
    • 12.2.1. Consoles And Control Units
    • 12.2.2. Light Sources
    • 12.2.3. Footswitches
    • 12.2.4. Reusable Instruments

13. Vitrectomy Devices Market, by Surgery Setting

  • 13.1. Inpatient Settings
  • 13.2. Outpatient And Day Care Settings
  • 13.3. Office-Based Settings

14. Vitrectomy Devices Market, by Clinical Application

  • 14.1. Diabetic Retinopathy
    • 14.1.1. Proliferative Diabetic Retinopathy
    • 14.1.2. Diabetic Macular Edema
  • 14.2. Retinal Detachment
    • 14.2.1. Rhegmatogenous Retinal Detachment
    • 14.2.2. Tractional Retinal Detachment
    • 14.2.3. Combined Mechanism Detachment
  • 14.3. Macular Disorders
    • 14.3.1. Macular Hole
    • 14.3.2. Epiretinal Membrane
  • 14.4. Vitreous Hemorrhage
  • 14.5. Uveitis And Endophthalmitis
  • 14.6. Ocular Trauma

15. Vitrectomy Devices Market, by End User

  • 15.1. Hospitals
    • 15.1.1. Tertiary Care Hospitals
    • 15.1.2. Community Hospitals
  • 15.2. Ophthalmic Clinics
    • 15.2.1. Single-Specialty Clinics
    • 15.2.2. Multi-Specialty Clinics
  • 15.3. Ambulatory Surgical Centers
  • 15.4. Academic And Research Institutes

16. Vitrectomy Devices Market, by Sales Channel

  • 16.1. Direct Sales
    • 16.1.1. Institutional Tenders
    • 16.1.2. Direct To Physicians
  • 16.2. Distributor Sales
  • 16.3. Online And E-Procurement Platforms

17. Vitrectomy Devices Market, by Region

  • 17.1. Americas
    • 17.1.1. North America
    • 17.1.2. Latin America
  • 17.2. Europe, Middle East & Africa
    • 17.2.1. Europe
    • 17.2.2. Middle East
    • 17.2.3. Africa
  • 17.3. Asia-Pacific

18. Vitrectomy Devices Market, by Group

  • 18.1. ASEAN
  • 18.2. GCC
  • 18.3. European Union
  • 18.4. BRICS
  • 18.5. G7
  • 18.6. NATO

19. Vitrectomy Devices Market, by Country

  • 19.1. United States
  • 19.2. Canada
  • 19.3. Mexico
  • 19.4. Brazil
  • 19.5. United Kingdom
  • 19.6. Germany
  • 19.7. France
  • 19.8. Russia
  • 19.9. Italy
  • 19.10. Spain
  • 19.11. China
  • 19.12. India
  • 19.13. Japan
  • 19.14. Australia
  • 19.15. South Korea

20. United States Vitrectomy Devices Market

21. China Vitrectomy Devices Market

22. Competitive Landscape

  • 22.1. Market Concentration Analysis, 2025
    • 22.1.1. Concentration Ratio (CR)
    • 22.1.2. Herfindahl Hirschman Index (HHI)
  • 22.2. Recent Developments & Impact Analysis, 2025
  • 22.3. Product Portfolio Analysis, 2025
  • 22.4. Benchmarking Analysis, 2025
  • 22.5. Alcon Inc.
  • 22.6. Bausch + Lomb Corporation
  • 22.7. Blink Medical Ltd.
  • 22.8. BVI Medical, Inc.
  • 22.9. Carl Zeiss Meditec AG
  • 22.10. D.O.R.C. Holding B.V.
  • 22.11. Geuder AG
  • 22.12. Haag-Streit Holding AG
  • 22.13. HOYA Medical Singapore Pte. Ltd.
  • 22.14. Iridex Corporation
  • 22.15. Johnson & Johnson Vision Care, Inc.
  • 22.16. MedOne Surgical, Inc.
  • 22.17. Medtronic plc
  • 22.18. NIDEK Co., Ltd.
  • 22.19. OCULUS Optikgerate GmbH
  • 22.20. Oertli Instrumente AG
  • 22.21. Peregrine Surgical LLC
  • 22.22. Synergetics USA, Inc.
  • 22.23. Topcon Corporation

LIST OF FIGURES

  • FIGURE 1. GLOBAL VITRECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 2. GLOBAL VITRECTOMY DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 3. GLOBAL VITRECTOMY DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 4. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 5. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 6. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY GAUGE SIZE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 7. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 8. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY USAGE PATTERN, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 9. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGERY SETTING, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 11. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SALES CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 13. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 15. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. UNITED STATES VITRECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 17. CHINA VITRECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL VITRECTOMY DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INTEGRATED PHACO-VITRECTOMY SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INTEGRATED PHACO-VITRECTOMY SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INTEGRATED PHACO-VITRECTOMY SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY STANDALONE VITRECTOMY CONSOLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY STANDALONE VITRECTOMY CONSOLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY STANDALONE VITRECTOMY CONSOLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY PROBES, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC AND HYPERSONIC PROBES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC AND HYPERSONIC PROBES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC AND HYPERSONIC PROBES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FIBER OPTIC ILLUMINATION CABLES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FIBER OPTIC ILLUMINATION CABLES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FIBER OPTIC ILLUMINATION CABLES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PACKAGED DISPOSABLE KITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PACKAGED DISPOSABLE KITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PACKAGED DISPOSABLE KITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUSTOM PROCEDURE PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUSTOM PROCEDURE PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUSTOM PROCEDURE PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INFUSION LINES AND TUBING, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INFUSION LINES AND TUBING, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INFUSION LINES AND TUBING, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES AND CONTROL PEDALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES AND CONTROL PEDALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES AND CONTROL PEDALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION AND VIEWING ACCESSORIES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION AND VIEWING ACCESSORIES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION AND VIEWING ACCESSORIES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION AND VIEWING ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT LENSES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT LENSES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT LENSES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TECHNOLOGY TYPE, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUTTING MECHANISM TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUTTING MECHANISM TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUTTING MECHANISM TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CUTTING MECHANISM TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC CUTTING TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC CUTTING TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PNEUMATIC CUTTING TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC CUTTING TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC CUTTING TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ELECTRIC CUTTING TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ULTRASONIC AND HYPERSONIC TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ULTRASONIC AND HYPERSONIC TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ULTRASONIC AND HYPERSONIC TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY XENON ILLUMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY XENON ILLUMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY XENON ILLUMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LED ILLUMINATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LED ILLUMINATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LED ILLUMINATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FLUIDICS MANAGEMENT TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FLUIDICS MANAGEMENT TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FLUIDICS MANAGEMENT TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FLUIDICS MANAGEMENT TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PERISTALTIC PUMP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PERISTALTIC PUMP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PERISTALTIC PUMP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VENTURI PUMP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VENTURI PUMP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VENTURI PUMP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HYBRID PUMP SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HYBRID PUMP SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HYBRID PUMP SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION TECHNOLOGY, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT VIEWING TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT VIEWING TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONTACT VIEWING TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING TECHNOLOGY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING TECHNOLOGY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY NON-CONTACT VIEWING TECHNOLOGY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIGITAL VISUALIZATION SYSTEMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIGITAL VISUALIZATION SYSTEMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIGITAL VISUALIZATION SYSTEMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY GAUGE SIZE, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 20 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 20 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 20 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 23 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 23 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 23 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 25 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 25 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 25 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 27 GAUGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 27 GAUGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY 27 GAUGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 129. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 130. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY POSTERIOR SEGMENT PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 131. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY POSTERIOR SEGMENT PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 132. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY POSTERIOR SEGMENT PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 133. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY POSTERIOR SEGMENT PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 134. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PARS PLANA VITRECTOMY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 135. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PARS PLANA VITRECTOMY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 136. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PARS PLANA VITRECTOMY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 137. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 138. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 139. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT REPAIR, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 140. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR SURGERY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 141. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR SURGERY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 142. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR SURGERY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 143. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR SEGMENT PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 144. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR SEGMENT PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 145. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR SEGMENT PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 146. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR SEGMENT PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 147. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY DURING CATARACT SURGERY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 148. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY DURING CATARACT SURGERY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 149. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY DURING CATARACT SURGERY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 150. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY FOR LENS COMPLICATIONS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 151. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY FOR LENS COMPLICATIONS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 152. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ANTERIOR VITRECTOMY FOR LENS COMPLICATIONS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 153. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 154. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 155. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 156. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 157. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PHACO-VITRECTOMY PROCEDURES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 158. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PHACO-VITRECTOMY PROCEDURES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 159. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PHACO-VITRECTOMY PROCEDURES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 160. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY WITH SECONDARY LENS IMPLANTATION, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 161. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY WITH SECONDARY LENS IMPLANTATION, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 162. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY WITH SECONDARY LENS IMPLANTATION, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 163. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY USAGE PATTERN, 2018-2032 (USD MILLION)
  • TABLE 164. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-USE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 165. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-USE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 166. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-USE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 167. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-USE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 168. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROBES AND CUTTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 169. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROBES AND CUTTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 170. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROBES AND CUTTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 171. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 172. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 173. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CANNULAS AND TROCARS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 174. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 175. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 176. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 177. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 178. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 179. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE DEVICES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 180. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE DEVICES, 2018-2032 (USD MILLION)
  • TABLE 181. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONSOLES AND CONTROL UNITS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 182. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONSOLES AND CONTROL UNITS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 183. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CONSOLES AND CONTROL UNITS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 184. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 185. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 186. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY LIGHT SOURCES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 187. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 188. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 189. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY FOOTSWITCHES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 190. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE INSTRUMENTS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 191. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE INSTRUMENTS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 192. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REUSABLE INSTRUMENTS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 193. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SURGERY SETTING, 2018-2032 (USD MILLION)
  • TABLE 194. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INPATIENT SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 195. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INPATIENT SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 196. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INPATIENT SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 197. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OUTPATIENT AND DAY CARE SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 198. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OUTPATIENT AND DAY CARE SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 199. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OUTPATIENT AND DAY CARE SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 200. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OFFICE-BASED SETTINGS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 201. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OFFICE-BASED SETTINGS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 202. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OFFICE-BASED SETTINGS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 203. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY CLINICAL APPLICATION, 2018-2032 (USD MILLION)
  • TABLE 204. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 205. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 206. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 207. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC RETINOPATHY, 2018-2032 (USD MILLION)
  • TABLE 208. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 209. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 210. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY PROLIFERATIVE DIABETIC RETINOPATHY, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 211. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 212. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 213. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIABETIC MACULAR EDEMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 214. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 215. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 216. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 217. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RETINAL DETACHMENT, 2018-2032 (USD MILLION)
  • TABLE 218. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RHEGMATOGENOUS RETINAL DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 219. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RHEGMATOGENOUS RETINAL DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 220. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY RHEGMATOGENOUS RETINAL DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 221. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TRACTIONAL RETINAL DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 222. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TRACTIONAL RETINAL DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 223. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TRACTIONAL RETINAL DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 224. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED MECHANISM DETACHMENT, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED MECHANISM DETACHMENT, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMBINED MECHANISM DETACHMENT, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 227. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR DISORDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 228. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR DISORDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 229. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR DISORDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 230. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR DISORDERS, 2018-2032 (USD MILLION)
  • TABLE 231. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR HOLE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 232. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR HOLE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 233. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MACULAR HOLE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 234. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 235. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 236. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY EPIRETINAL MEMBRANE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 237. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITREOUS HEMORRHAGE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 238. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITREOUS HEMORRHAGE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 239. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY VITREOUS HEMORRHAGE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 240. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY UVEITIS AND ENDOPHTHALMITIS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 241. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY UVEITIS AND ENDOPHTHALMITIS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 242. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY UVEITIS AND ENDOPHTHALMITIS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 243. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OCULAR TRAUMA, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 244. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OCULAR TRAUMA, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 245. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OCULAR TRAUMA, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 246. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 247. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 248. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 249. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 250. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY HOSPITALS, 2018-2032 (USD MILLION)
  • TABLE 251. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 252. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 253. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY TERTIARY CARE HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 254. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 255. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 256. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY COMMUNITY HOSPITALS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 257. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 258. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 259. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 260. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY OPHTHALMIC CLINICS, 2018-2032 (USD MILLION)
  • TABLE 261. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 262. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 263. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SINGLE-SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 264. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 265. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 266. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY MULTI-SPECIALTY CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 267. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 268. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 269. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 270. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 271. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 272. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ACADEMIC AND RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 273. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY SALES CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 275. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 276. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 277. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT SALES, 2018-2032 (USD MILLION)
  • TABLE 278. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INSTITUTIONAL TENDERS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 279. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INSTITUTIONAL TENDERS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 280. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY INSTITUTIONAL TENDERS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 281. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT TO PHYSICIANS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 282. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT TO PHYSICIANS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 283. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DIRECT TO PHYSICIANS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 284. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 285. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 286. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY DISTRIBUTOR SALES, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 287. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ONLINE AND E-PROCUREMENT PLATFORMS, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 288. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ONLINE AND E-PROCUREMENT PLATFORMS, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 289. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY ONLINE AND E-PROCUREMENT PLATFORMS, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 290. GLOBAL VITRECTOMY DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 291. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
  • TABLE 292. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 293. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY SYSTEMS, 2018-2032 (USD MILLION)
  • TABLE 294. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY VITRECTOMY PROBES, 2018-2032 (USD MILLION)
  • TABLE 295. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY ILLUMINATION DEVICES, 2018-2032 (USD MILLION)
  • TABLE 296. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY SURGICAL PACKS, 2018-2032 (USD MILLION)
  • TABLE 297. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY ACCESSORIES, 2018-2032 (USD MILLION)
  • TABLE 298. AMERICAS VITRECTOMY DEVICES MARKET SIZE, BY VISUALIZATION AND VIEW